Human Lung Responses to Respiratory Pathogens
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Human Lung Responses to Respiratory Pathogens is a clinical trial[1].
Key Facts
- Human Lung Responses to Respiratory Pathogens is in the country of United States[2].
- Human Lung Responses to Respiratory Pathogens's instance of is recorded as clinical trial[3].
- Human Lung Responses to Respiratory Pathogens's start time is recorded as +2007-06-30T00:00:00Z[4].
- Human Lung Responses to Respiratory Pathogens's end time is recorded as +2010-07-31T00:00:00Z[5].
- Human Lung Responses to Respiratory Pathogens's sponsor is recorded as University of Iowa[6].
- Human Lung Responses to Respiratory Pathogens's main subject is recorded as rickets[7].
- Human Lung Responses to Respiratory Pathogens's number of participants is recorded as {'unit': '1', 'amount': '+98'}[8].
- Human Lung Responses to Respiratory Pathogens's title is recorded as Human Lung Responses to Respiratory Pathogens[9].
- Human Lung Responses to Respiratory Pathogens's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- Human Lung Responses to Respiratory Pathogens's ClinicalTrials.gov ID is recorded as NCT01967628[11].
- Human Lung Responses to Respiratory Pathogens's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[12].
- Human Lung Responses to Respiratory Pathogens's research intervention is recorded as (5R)-24,25-Dihydroxyvitamin D[13].
- Human Lung Responses to Respiratory Pathogens's research intervention is recorded as Ergocalciferols[14].
- Human Lung Responses to Respiratory Pathogens's research intervention is recorded as cholecalciferol[15].
- Human Lung Responses to Respiratory Pathogens's clinical trial phase is recorded as phase I clinical trial[16].
- Human Lung Responses to Respiratory Pathogens's clinical trial phase is recorded as phase II clinical trial[17].
- Human Lung Responses to Respiratory Pathogens's research site is recorded as University of Iowa Health Care[18].
- Human Lung Responses to Respiratory Pathogens's research subject recruitment status is recorded as completed[19].
- Human Lung Responses to Respiratory Pathogens's study type is recorded as interventional study[20].